Diet over drugs: eHealth trial aims to remit type 2 diabetes

NCT ID NCT05491005

Recruiting now Disease control Sponsor: Umeå University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a total diet replacement of just 850 calories per day for 3 months, followed by weight maintenance, can help people with type 2 diabetes achieve remission. Participants are randomly assigned to follow-up via an eHealth app or in-person visits. The goal is to see if eHealth support is as effective as face-to-face care for long-term diabetes control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: total diet replacement (850 kcal/day)
What this could lead to: If successful, this could show that intensive diet and eHealth follow-up can help many people with type 2 diabetes achieve remission without medication.
What could go wrong: This is a small, early-stage trial with only 106 participants, and the diet is very restrictive, which may be hard to maintain. Remission may not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity type 2 diabetes mellitus Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Bra Liv Råslätt vårdcentral
RECRUITING

Jönköping, Sweden
Department of Public Health and Clinical Medicine, Medicine
RECRUITING

Umeå, 90187, Sweden
Örnsköldsvik hospital
NOT_YET_RECRUITING

Örnsköldsvik, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.